Premium
Racial differences in prevalence of a supratypic HLA‐genetic marker immaterial to pre‐employment testing for susceptibility to chronic beryllium disease
Author(s) -
Weston Ainsley,
Ensey James,
Kreiss Kathleen,
Keshava Channa,
McCanlies Erin
Publication year - 2002
Publication title -
american journal of industrial medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 104
eISSN - 1097-0274
pISSN - 0271-3586
DOI - 10.1002/ajim.10072
Subject(s) - medicine , odds ratio , population , disease , genotyping , human leukocyte antigen , immunology , demography , genetics , genotype , antigen , biology , environmental health , gene , sociology
Background A beryllium materials manufacturer is conducting a limited pilot program that offers testing for HLA‐DPβ1 E69 with genetic counseling through a third party to applicants for employment. An important consideration in this regard is the prevalence of this marker in the general population, and its consequent positive predictive value of disease susceptibility. Methods Polymerase chain reaction and restriction fragment length polymorphism analyses were used to determine HLA‐DPβ1 E69 population frequencies. Estimation of positive predictive values assumed a disease frequency among beryllium workers of either 5 or 15% and used an odds ratio for disease risk of 35 for the HLA‐DPβ1 E69 marker. Results Allelic/carrier frequencies were found to be 0.21/0.33, 0.24/0.40, 0.27/0.47, and 0.38/0.59 for Caucasians, African‐Americans, Hispanics, and Chinese, respectively. Ranges of positive predictive values for a genetic test based on HLA‐DPβ1 E69 in these populations were calculated to be 8.3–14.3% for carriers with an assumed disease frequency of 5%. For high risk subgroups with disease frequencies of 15%, the range of positive predictive values was found to span between 24.9–43.0%. Conclusions These estimates suggest that using HLA‐DPβ1 E69 genotyping for general pre‐employment screening in the beryllium industry has a low positive predictive value, which varies little among racial groups where carrier frequencies differ significantly. Am. J. Ind. Med. 41:457–465, 2002. © 2002 Wiley‐Liss, Inc.